# New View Surgical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/new-view-surgical

- Industry: Medical Devices & Equipment
- Headquarters: Andover, US
- Website: www.newviewsurg.com
- Total disclosed funding: $12M
- Latest round: Series B (Nov 2, 2021)
- Investors on record: 8

## About

New View Surgical, Inc. is a US-based company focused on advanced solutions for minimally invasive surgical procedures, enhancing surgical access and visualization to improve patient outcomes.Founded in 2009 in Andover, US, New View Surgical, Inc. specializes in innovative surgical tools. The company has raised USD 7.02 mn through Series B funding as part of a USD 10 mn round, focusing on enhancing surgical technology. Jesse Plouffe is the founder, and Bryce Klontz currently serves as CEO. The company has completed a total of 5 funding deals, with the latest deal occurring on September 15, 2022, leading to a current valuation of USD 42.52 mn.New View Surgical specializes in providing advanced solutions for minimally invasive surgical procedures, primarily through their flagship product, VisionPort. This innovative tool enhances visualization and access during surgical operations, aiming to simplify complex procedures while improving patient outcomes. The company's core offerings cater to the growing demand for less invasive surgical options in general surgery, gynecology, and urology. New View Surgical serves hospitals, surgical centers, and healthcare professionals across North America and Europe, focusing on the demand for improved surgical equipment.New View Surgical generates revenue primarily through direct sales of its VisionPort system and associated surgical tools to healthcare facilities and professionals. The company’s business-to-business transactions involve partnerships with hospitals and surgical centers that utilize their products in operating rooms. Revenue is derived from the sale of individual units and consumables related to their surgical systems, supporting healthcare providers in enhancing surgical efficiency and patient safety. The pricing structure is designed to reflect the value of improving surgical outcomes and operational efficiencies for end-users.In September 2022, New View Surgical, Inc. raised USD 7.02 mn in Series B funding, which will be utilized to introduce its product before the end of the year in the US market. The company plans to expand geographically into new regions with a focus on increasing market penetration. Specific future product releases have not been detailed, but the intent is to enhance their product offerings in minimally invasive surgical solutions.

## Funding rounds

- Series B, Nov 2, 2021, $9M — Keiretsu Forum, Mid Atlantic Bio Angels, Charleston Angel Partners, Ariel Southeast Angel Partners, IAG Capital Partners, Corza Medical, SSIP, New York Angels
- Series A, Jun 17, 2019, $2.5M — Keiretsu Forum, Mid Atlantic Bio Angels, Ariel Southeast Angel Partners, New York Angels

## Investors

- Keiretsu Forum — Series A, Series B
- Mid Atlantic Bio Angels (https://capitalatlas.ai/funds/mid-atlantic-bio-angels) — Series A, Series B
- Ariel Southeast Angel Partners (https://capitalatlas.ai/funds/ariel-southeast-angel-partners) — Series A, Series B
- New York Angels (https://capitalatlas.ai/funds/new-york-angels) — Series A, Series B
- Charleston Angel Partners — Series B
- IAG Capital Partners (https://capitalatlas.ai/funds/iag-capital-partners) — Series B
- Corza Medical — Series B
- SSIP — Series B